Stanford Neuromodulation Therapy (SNT): A Double-Blind Randomized Controlled Trial

难治性抑郁症 萧条(经济学) 随机对照试验 心理学 临床全球印象 神经调节 安慰剂 医学 重性抑郁障碍 内科学 精神科 刺激 神经科学 认知 替代医学 病理 经济 宏观经济学
作者
Eleanor J. Cole,Angela Phillips,Brandon S. Bentzley,Katy H. Stimpson,Romina Nejad,Fahim Barmak,Clive Veerapal,Naushaba Khan,Kirsten N. Cherian,Emily Felber,Randi E. Brown,Elizabeth Choi,Sinéad King,Heather Pankow,James H. Bishop,Azeezat Azeez,John P. Coetzee,Rachel Rapier,Nicole Odenwald,David M. Carreon
出处
期刊:American Journal of Psychiatry [American Psychiatric Association]
卷期号:179 (2): 132-141 被引量:889
标识
DOI:10.1176/appi.ajp.2021.20101429
摘要

OBJECTIVE: Depression is the leading cause of disability worldwide, and half of patients with depression have treatment-resistant depression. Intermittent theta-burst stimulation (iTBS) is approved by the U.S. Food and Drug Administration for the treatment of treatment-resistant depression but is limited by suboptimal efficacy and a 6-week duration. The authors addressed these limitations by developing a neuroscience-informed accelerated iTBS protocol, Stanford neuromodulation therapy (SNT; previously referred to as Stanford accelerated intelligent neuromodulation therapy, or SAINT). This protocol was associated with a remission rate of ∼90% after 5 days of open-label treatment. Here, the authors report the results of a sham-controlled double-blind trial of SNT for treatment-resistant depression. METHODS: Participants with treatment-resistant depression currently experiencing moderate to severe depressive episodes were randomly assigned to receive active or sham SNT. Resting-state functional MRI was used to individually target the region of the left dorsolateral prefrontal cortex most functionally anticorrelated with the subgenual anterior cingulate cortex. The primary outcome was score on the Montgomery-Åsberg Depression Rating Scale (MADRS) 4 weeks after treatment. RESULTS: At the planned interim analysis, 32 participants with treatment-resistant depression had been enrolled, and 29 participants who continued to meet inclusion criteria received either active (N=14) or sham (N=15) SNT. The mean percent reduction from baseline in MADRS score 4 weeks after treatment was 52.5% in the active treatment group and 11.1% in the sham treatment group. CONCLUSIONS: SNT, a high-dose iTBS protocol with functional-connectivity-guided targeting, was more effective than sham stimulation for treatment-resistant depression. Further trials are needed to determine SNT's durability and to compare it with other treatments.
最长约 10秒,即可获得该文献文件

科研通智能强力驱动
Strongly Powered by AbleSci AI
科研通是完全免费的文献互助平台,具备全网最快的应助速度,最高的求助完成率。 对每一个文献求助,科研通都将尽心尽力,给求助人一个满意的交代。
实时播报
1秒前
月棺轻城完成签到,获得积分10
1秒前
1秒前
L_eternity发布了新的文献求助10
2秒前
hope完成签到 ,获得积分10
2秒前
Luo完成签到,获得积分10
2秒前
华仔的应助被聚乙二醇采纳,获得10
2秒前
科研通AI6.2的应助被zhuzhenghua采纳,获得10
3秒前
Yiling完成签到,获得积分10
4秒前
张晗发布了新的文献求助10
5秒前
安详芝发布了新的文献求助30
5秒前
魔幻的如冰完成签到,获得积分10
5秒前
田様的应助被哆啦小孟采纳,获得10
5秒前
星辰大海的应助被聚乙二醇采纳,获得10
5秒前
情怀的应助被12581采纳,获得10
6秒前
7秒前
bluee发布了新的文献求助10
8秒前
8秒前
8秒前
李健的应助被聚乙二醇采纳,获得10
8秒前
脑洞疼的应助被Cc采纳,获得10
8秒前
还是别了叭完成签到,获得积分20
9秒前
贪玩夏蓉完成签到,获得积分10
9秒前
科研通AI6.2的应助被张丁采纳,获得10
10秒前
李健的应助被聚乙二醇采纳,获得10
11秒前
缥缈的半芹完成签到 ,获得积分10
11秒前
英俊的铭的应助被勤奋一一采纳,获得10
12秒前
YunjiangZhang发布了新的文献求助10
12秒前
ray101023发布了新的文献求助10
12秒前
13秒前
所所的应助被聚乙二醇采纳,获得10
14秒前
852的应助被香蕉梨愁采纳,获得10
14秒前
学术渣滓完成签到,获得积分10
14秒前
赘婿的应助被文章大发采纳,获得10
14秒前
所所的应助被DDY采纳,获得10
15秒前
15秒前
15秒前
15秒前
15秒前
16秒前
高分求助中
(应助此贴封号)【重要!!请各用户(尤其是新用户)详细阅读】【科研通的精品贴汇总】 10000
拉伸高分子熔体中缠结行为的模拟和小角中子散射研究 1700
The World Atlas of Wine 9th edition 1000
奈特基础组织学:配套组织病理学(第4版)(Netter's Essential Histology With Correlated Histopathology) 800
John McDowells Bildungstheorie 800
Markov Decision Processes and Reinforcement Learning 700
八旗制度の研究 600
热门求助领域 (近24小时)
化学 材料科学 医学 生物 纳米技术 计算机科学 工程类 有机化学 化学工程 生物化学 物理 复合材料 内科学 催化作用 光电子学 人工智能 细胞生物学 无机化学 物理化学 数学
热门帖子
关注 科研通微信公众号,转发送积分 8170973
求助须知:如何正确求助?哪些是违规求助? 9563727
关于积分的说明 21771951
捐赠科研通 7762452
什么是DOI,文献DOI怎么找? 3430786
关于科研通互助平台的介绍 2554629
邀请新用户注册赠送积分活动 2475637